Skip to content

DR C. MALENGREAUX: what changed

BE 0753.530.543NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€40,635
2024 · €32,070+€8,565
Equity
€8,111
2024 · €40,476-€32,365
Cash
€51,470
2024 · €56,237-€4,767
Balance sheet total
€118,412
2024 · €134,977-€16,565

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income -€12,088

    down €12,088 (-82.6%), from €14,630 to €2,542

  • Cash -€4,767

    down €4,767 (-8.5%), from €56,237 to €51,470

    mainly Contributions, distributions and other (-€73,000) and Receivables within one year (-€979)

Equity and liabilities
  • Profit (loss) carried forward -€32,365

    down €32,365 (-99.7%), from €32,476 to €111

  • Tax, wage and social debts +€8,385

    up €8,385 (+237%), from €3,545 to €11,930

  • Other debts +€7,231

    up €7,231 (+8.0%), from €90,054 to €97,285

Income statement
  • Depreciation -€8,854

    down €8,854 (-92.8%), from €9,542 to €688

  • Taxes +€4,908

    up €4,908 (+45.1%), from €10,873 to €15,780

  • Gross operating margin +€4,479

    up €4,479 (+8.6%), from €51,996 to €56,476

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €32,070
Gross operating margin +€4,479
Depreciation +€8,854
Other operating charges +€79
Financial income -€15
Financial charges +€75
Taxes -€4,908
Result 2025 €40,635
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€68,233
Investment €0
Financing -€73,000
Cash 2024 €56,237
Net result for the year +€40,635
Depreciation +€688
Receivables within one year -€979
Deferred charges and accrued income +€12,088
Trade debts -€267
Tax, wage and social debts +€8,385
Other debts +€7,231
Accrued charges and deferred income +€451
Contributions, distributions and other -€73,000
Cash 2025 €51,470
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €134,977 €118,412 -€16,565 -12.3%
Fixed assets 21/28 €2,972 €2,284 -€688 -23.1%
Tangible fixed assets 22/27 €2,972 €2,284 -€688 -23.1%
Furniture and vehicles 24 €2,972 €2,284 -€688 -23.1%
Current assets 29/58 €132,005 €116,128 -€15,877 -12.0%
Amounts receivable within one year 40/41 €61,137 €62,116 +€979 +1.6%
Other amounts receivable 41 €61,137 €62,116 +€979 +1.6%
Cash at bank and in hand 54/58 €56,237 €51,470 -€4,767 -8.5%
Deferred charges and accrued income 490/1 €14,630 €2,542 -€12,088 -82.6%
Total equity and liabilities 10/49 €134,977 €118,412 -€16,565 -12.3%
Equity 10/15 €40,476 €8,111 -€32,365 -80.0%
Contributions 10/11 €8,000 €8,000 = 0.0%
Profit (loss) carried forward 14 €32,476 €111 -€32,365 -99.7%
Amounts payable 17/49 €94,501 €110,301 +€15,800 +16.7%
Amounts payable within one year 42/48 €94,452 €109,801 +€15,349 +16.3%
Trade debts 44 €853 €586 -€267 -31.3%
Suppliers 440/4 €853 €586 -€267 -31.3%
Taxes, remuneration and social security 45 €3,545 €11,930 +€8,385 +237%
Taxes 450/3 €3,545 €11,930 +€8,385 +237%
Other amounts payable 47/48 €90,054 €97,285 +€7,231 +8.0%
Accrued charges and deferred income 492/3 €49 €500 +€451 +914%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,542 €688 -€8,854 -92.8%
Other operating charges 640/8 €1,041 €962 -€79 -7.6%
Gross operating margin 9900 €51,996 €56,476 +€4,479 +8.6%
Operating profit (loss) 9901 €41,414 €54,826 +€13,412 +32.4%
Financial income 75/76B €1,716 €1,701 -€15 -0.9%
Recurring financial income 75 €1,716 €1,701 -€15 -0.9%
Financial charges 65/66B €186 €111 -€75 -40.4%
Recurring financial charges 65 €186 €111 -€75 -40.4%
Profit (loss) for the period before taxes 9903 €42,943 €56,415 +€13,472 +31.4%
Income taxes 67/77 €10,873 €15,780 +€4,908 +45.1%
Profit (loss) for the period 9904 €32,070 €40,635 +€8,565 +26.7%
Profit (loss) for the period to be appropriated 9905 €32,070 €40,635 +€8,565 +26.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€96,495 to €133,471

Midpoint €111,902 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €8,111
Capitalised earnings €184,879 to €258,830
Indication €96,495 to €133,471

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€8,111
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€8,111

Capitalised earnings

net result for the year (9904)
2025
€40,635
2024
€32,070
2023
€4,943
2022
€39,591
2021
€62,022
Average result
€25,883
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€184,879 / €215,692 / €258,830

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.